A phase Ib study of the FGFR/VEGFR inhibitor dovitinib with gemcitabine and capecitabine in advanced solid tumor and pancreatic cancer patients

OBJECTIVES: Preclinical studies demonstrated antitumor activity of dovitinib in pancreatic cancer models. This phase Ib study aimed to determine the maximum tolerated dose of dovitinib in combination with gemcitabine and capecitabine and to characterize the safety and pharmacokinetic profile in pati...

全面介紹

Na minha lista:
書目詳細資料
發表在:Am J Clin Oncol
Main Authors: Ma, Wen Wee, Xie, Hao, Fetterly, Gerald, Pitzonka, Laura, Whitworth, Amy, LeVea, Charles, Wilton, John, Mantione, Krystin, Schihl, Sarah, Dy, Grace K, Boland, Patrick, Iyer, Renuka, Tan, Wei, Brady, William, Straubinger, Robert M, Adjei, Alex A
格式: Artigo
語言:Inglês
出版: 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6345595/
https://ncbi.nlm.nih.gov/pubmed/30418178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000492
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍